IPX · Iperionx Ltd - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q2 '26 | Q2 '25 | Q4 '24 | Q2 '24 | Q4 '23 | Q2 '23 | Q4 '22 | Q2 '22 | Q4 '21 | Q2 '21 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - | - | - | - | - |
| SG&A | - | - | - | - | - | - | - | - | - | - |
| Total Operating Expenses | - | - | - | - | - | - | - | - | - | - |
| D&A | - | - | - | - | - | - | - | - | - | - |
| Operating Income | - | - | - | - | - | - | - | - | - | - |
| Interest Expense | - | - | - | - | - | - | - | - | - | - |
| Income Tax | - | - | - | - | - | - | - | - | - | - |
| Net Income | - | - | - | - | - | - | - | - | - | - |
| EPS - Basic | - | - | - | - | - | - | - | - | - | - |
| EPS - Diluted | - | - | - | - | - | - | - | - | - | - |
Balance Sheet
| Line item | Q2 '26 | Q2 '25 | Q4 '24 | Q2 '24 | Q4 '23 | Q2 '23 | Q4 '22 | Q2 '22 | Q4 '21 | Q2 '21 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $65.83M | $54.81M | $77.13M | $33.16M | $17.33M | $11.94M | $11.44M | $5.67M | $14.26M | $1.70M |
| Accounts Receivable | $1.15M | $823.3K | $977.3K | $2.30M | $2.70M | $228.4K | $84.5K | $22.5K | - | $341 |
| Inventory | $425.7K | $0 | $0 | $16.9K | - | $0 | - | - | - | - |
| Accounts Payable | $10.37M | $7.49M | $6.10M | $2.32M | $2.19M | $1.18M | $1.47M | $1.90M | - | $544.8K |
| Current Assets | $69.57M | $58.88M | $78.78M | $41.55M | $23.56M | $12.75M | $11.78M | $5.84M | - | $1.75M |
| Total Assets | $129.16M | $105.03M | $115.83M | $55.44M | $34.04M | $22.80M | $18.00M | $9.91M | - | $2.79M |
| Current Liabilities | $17.27M | $8.43M | $6.67M | $3.05M | $2.63M | $1.65M | $1.83M | $2.08M | - | $637.0K |
| Long-term Debt | - | - | - | - | - | - | - | - | - | - |
| Total Liabilities | $20.95M | $12.59M | $10.29M | $4.10M | $3.87M | $2.24M | $2.62M | $2.49M | - | $1.03M |
| Stockholders' Equity | $108.20M | $92.44M | $105.54M | $51.34M | $30.18M | $20.56M | $15.38M | $7.42M | $15.05M | $1.76M |
| Retained Earnings | ($144.00M) | ($109.23M) | ($90.12M) | ($73.88M) | ($62.69M) | ($52.20M) | ($43.51M) | ($34.75M) | - | ($13.23M) |
Cash Flow
| Line item | Q2 '26 | Q2 '25 | Q4 '24 | Q2 '24 | Q4 '23 | Q2 '23 | Q4 '22 | Q2 '22 | Q4 '21 | Q2 '21 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - | - | - | - | - |
| Investing Cash Flow | - | - | - | - | - | - | - | - | - | - |
| Financing Cash Flow | - | - | - | - | - | - | - | - | - | - |
| CapEx | - | - | - | - | - | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - | - | - | - | - | - |
Ratios
| Metric | Q2 '26 | Q2 '25 | Q4 '24 | Q2 '24 | Q4 '23 | Q2 '23 | Q4 '22 | Q2 '22 | Q4 '21 | Q2 '21 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | - | - | - | - | - | - | - | - | - | - |
| Operating margin | - | - | - | - | - | - | - | - | - | - |
| EBITDA margin | - | - | - | - | - | - | - | - | - | - |
| Net margin | - | - | - | - | - | - | - | - | - | - |
| Free cash flow margin | - | - | - | - | - | - | - | - | - | - |
| FCF / Net income | - | - | - | - | - | - | - | - | - | - |
| R&D / Revenue | - | - | - | - | - | - | - | - | - | - |
| SG&A / Revenue | - | - | - | - | - | - | - | - | - | - |
| Effective tax rate | - | - | - | - | - | - | - | - | - | - |
| Return on assets | - | - | - | - | - | - | - | - | - | - |
| Return on equity | - | - | - | - | - | - | - | - | - | - |
| Return on invested capital | - | - | - | - | - | - | - | - | - | - |
| Liquidity | ||||||||||
| Current ratio | 4.03 | 6.99 | 11.80 | 13.62 | 8.97 | 7.74 | 6.43 | 2.81 | - | 2.74 |
| Quick ratio | 4.00 | 6.99 | 11.80 | 13.61 | 8.97 | 7.74 | 6.43 | 2.81 | - | 2.74 |
| Cash ratio | 3.81 | 6.50 | 11.56 | 10.87 | 6.60 | 7.25 | 6.24 | 2.73 | - | 2.67 |
| Leverage | ||||||||||
| Debt / Equity | - | - | - | - | - | - | - | - | - | - |
| Debt / Assets | - | - | - | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest coverage | - | - | - | - | - | - | - | - | - | - |
| Equity multiplier | 1.19 | 1.14 | 1.10 | 1.08 | 1.13 | 1.11 | 1.17 | 1.34 | - | 1.59 |
| Liabilities / Assets | 0.16 | 0.12 | 0.09 | 0.07 | 0.11 | 0.10 | 0.15 | 0.25 | - | 0.37 |
| Efficiency | ||||||||||
| Asset turnover | - | - | - | - | - | - | - | - | - | - |
| Inventory turnover | - | - | - | - | - | - | - | - | - | - |
| Days sales outstanding | - | - | - | - | - | - | - | - | - | - |
| Days inventory outstanding | - | - | - | - | - | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - | - | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - | - | - | - | - |
| Valuation | ||||||||||
| P / E | - | - | - | - | - | - | - | - | - | - |
| P / B | - | - | - | - | - | - | - | - | - | - |
| P / S | - | - | - | - | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Growth | ||||||||||
| Revenue growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| Revenue CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| Revenue CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Gross profit growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| Operating income growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| Net income growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| EPS growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| EPS CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| FCF growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | 17.0% | 80.1% | 249.8% | 149.7% | 96.3% | 177.1% | 2.2% | 321.5% | - | - |
Peer comparison
Same SIC group: Miscellaneous Metal Ores
Comparing IPERIONX Ltd against the 5 most active filers in the same SIC group.